# Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

> **NCT03914417** · PHASE2 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 21 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Imiquimod 3.75% Cream

## Key facts

- **NCT ID:** NCT03914417
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-04-30
- **Final completion:** 2015-04-30
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914417, "Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03914417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*